Swan-Ganz catheter for cardiogenic shock after heart attack
Part of Heart & circulation clinical trials.
This study tests whether a special catheter (Swan-Ganz) placed in the heart's blood vessels helps doctors better manage fluids and medications for people in cardiogenic shock after a heart attack. It aims to improve blood flow to vital organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cardiogenic shock from a recent heart attack, meaning your blood pressure is very low for at least 30 minutes or you need medicine to keep it up.
- You have signs that your organs aren't getting enough blood, like confusion, low urine output, cold skin, or high blood lactate levels.
- You do not have a neck infection or a history of neck radiation that would prevent catheter placement.
- You do not have a bleeding disorder (INR >1.5 or low platelets) or end-stage diseases like advanced cancer, advanced HIV, or severe liver cirrhosis.
- You do not have a heart defect present at birth or a hole between heart chambers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a special pressure-monitoring tube in the heart’s main artery (a pulmonary artery catheter) helps people who are in cardiogenic shock from weak heart pumping. If you qualify, the goal is to improve how doctors monitor and treat this dangerous, fast-moving condition.
This trial tests whether using a temporary heart pump plus close monitoring improves recovery in people with severe heart failure after a heart attack, compared to standard care.
This trial tests a treatment plan for people having a severe heart attack that causes cardiogenic shock, where the heart can't pump enough blood. The study uses a special heart pump to support patients during an emergency procedure to open blocked arteries.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
This trial tests if a temporary heart pump (IABP) can help patients who have had a heart attack and developed a hole in the wall between their heart chambers. Patients must be in an early, less severe stage of shock.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.